- Ranbaxy to market Daiichi's products in Romania
Drug firm Ranbaxy Laboratories today said its Romanian arm will market Daiichi Sankyo's drug Evista, used in treatment of osteoporosis, in ...
- Ranbaxy Lab's Romania unit to market osteoporosis drug
Pharma firm Ranbaxy Laboratories said its Romanian arm will market Evista, a drug used for treating osteoporosis.
- Ranbaxy to sell Terapia's liquid business
India’s largest pharmaceutical company Ranbaxy Laboratories is selling the oral liquid manufacturing unit of its Romanian subsidiary, Terap...
- India Inc shines on deal street
- Pharma companies to scale up Romania operations
Romania could soon become the hunting ground for Indian pharma companies who plan to strengthen their foothold in the European market.
- Ranbaxy considers acquisitions in US
Ranbaxy Laboratories Ltd, India's biggest drugmaker, considers acquisitions aimed at expanding operations in the US, south and central Amer...
- Terapia Ranbaxy's Bucharest site gets GMP nod
The Bucharest-based production facility of Terapia Ranbaxy has received a renewal of certification for Good Manufacturing Practice standard...
- Ranbaxy gains double on high US sales
Ranbaxy Laboratories’ net profit doubled to Rs 520 crore in December 2006, spurred by US sales of its copy of Merck & Co’s cholesterol-lowe...
- Romania's Damian to head Terapia-Ranbaxy
The template designed by India Inc of managing its global acquisitions with executives handpicked from the local milieu has received one mo...
- 3M's pharma sales close to $700m
Ranbaxy and Wockhardt are said to have lined up for 3M’s pharma business in the US. Both entities are looking to further their global ambit...
- Ranbaxy may sell its Irish unit
India's biggest drugmaker Ranbaxy Laboratories Ltd, which has decided to put its manufacturing unit in Ireland on the block, may sell it fo...
- Dishman Pharma buys Swiss co for Rs 349 cr
Hyderabad-based Dishman Pharmaceuticals and Chemicals on Wednesday said it has acquired Swiss research-based company Cabbogen Amcis AG.
- Ranbaxy to sell Ireland manufacturing unit
Ranbaxy Laboratories Ltd on Thursday said it will sell off its manufacturing unit in Ireland as it consolidates production activity for Eur...
- Ranbaxy’s on the prowl
Action in the Indian pharmaceutical industry seems to be revving up again. If insiders are to be believed, the sector may soon witness anot...
- Ranbaxy acquires GSK's generics business in Spain
Ranbaxy Laboratories said it has acquired Anglo-American drug maker GlaxoSmithKline’s Mundogen generic business in Spain for an undisclosed...
- Ranbaxy gets nod to buy 96.7% stake in Romanian co
Ranbaxy Laboratories said it has got approval from the Romanian Competition Council for acquiring 96.7% stake in Terapia.
- Ranbaxy completes Terapia acquisition
Ranbaxy Laboratories Ltd on Thursday said it has got approval from the Romanian Competition Council for acquiring 96.7 per cent stake in th...